- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04818021
Contribution of the Somatosensory System to Speech Perceptual Processing
February 17, 2026 updated by: Yale University
Contribution of the Somatosensory System to Speech Perceptual Processing Aim 3
These studies test the hypothesis that the repeated pairing of somatosensory inputs with speech sounds, such as occurs during speech motor learning, results in changes to the perceptual classification of speech sounds.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This study will assess changes to the perceptual classification of speech sounds that are related to repeated pairing of somatosensory and auditory inputs (as would occur during speech motor learning).
Before and after the training, base-line and post-training auditory perceptual performance will be examined in the absence of somatosensory stimulation, in order to evaluate the effects of the pairing on speech perception.
Perceptual classification and speech motor learning will both be assessed on a 0 to 100 scale.
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3A1G1
- McGill University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- right handed adults
- no known physical or neurological abnormalities
Exclusion Criteria:
- patients with:
- cardiac pacemaker
- surgical clips or values on the heart
- implants
- metal or metallic fragments in any part of the body
- pregnancy
- claustrophobia
- a personal or family history of epilepsy
- currently taking antipsychotic drugs
- currently taking antidepressant drugs
- currently taking antianxiety drugs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adaptation to Altered Auditory Feedback
|
Sensorimotor adaptation in speech
|
|
Experimental: Adaptation to Altered Auditory Feedback + Forward Skin Stretch
|
Sensorimotor adaptation in speech
Facial skin stretch
|
|
Experimental: Adaptation to Altered Auditory Feedback + Backward Skin Stretch
|
Sensorimotor adaptation in speech
Facial skin stretch
|
|
Experimental: Speech Repetition Control
|
Sensorimotor adaptation in speech
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech Motor Learning
Time Frame: Performance as measured at the end of learning (30 minute session)
|
Learning is assessed as the change in speech sounds (speech formant frequencies) on a 0 to 100 scale.
|
Performance as measured at the end of learning (30 minute session)
|
|
Speech Perception
Time Frame: Perception is evaluated prior to and after perceptual training (30 minute session)
|
Auditory speech perception evaluates auditory classification and is assessed on a 0 to 100 scale.
All conditions of skin stretch involve the same speech perception task.
|
Perception is evaluated prior to and after perceptual training (30 minute session)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Ostry, Haskins Laboratories
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Actual)
July 31, 2025
Study Completion (Actual)
July 31, 2025
Study Registration Dates
First Submitted
March 19, 2021
First Submitted That Met QC Criteria
March 23, 2021
First Posted (Actual)
March 26, 2021
Study Record Updates
Last Update Posted (Actual)
February 19, 2026
Last Update Submitted That Met QC Criteria
February 17, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000025475_b
- R01DC017439 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.